TranS1, Inc. was founded in 2000 by Dr. Andrew Cragg, a Minneapolis-based interventional surgeon who developed and patented the trans-sacral approach to accessing the spine for lumbar spine surgical procedures. The company is an early stage medical device company dedicated to advancing the minimally invasive technique for spine disorders. Rick Randall joined TranS1 as full time CEO in June 2002. Previously, Mr. Randall founded and served as President and CEO of Incumed, Inc., a medical device incubator. He also served as President and CEO of the sports medicine firm, Innovasive Devices, Inc., and was President, Chairman and Director of Target Therapeutics, Inc., a medical device company that pioneered the minimally invasive, interventional neurosurgery market. TranS1 is headquartered in Wilmington, North Carolina.